Huang, J., R. Khurana, A. Ghanekar, P. Wang, B. Day, B. Blodi, A. Domalpally, C. Quezada-Ruiz, and M. Ip. Disease-Modifying Effects of Ranibizumab for Central Retinal Vein Occlusion. Graefes Arch Clin Exp Ophthalmol., 2021, p. Epub PubMed Text.
Abstract
Purpose: To identify anatomic endpoints altered by intravitreal ranibizumab in central retinal vein occlusion (CRVO) to determine any potential underlying disease modification that occurs with anti-vascular endothelial growth factor (anti-VEGF) therapy beyond best-corrected visual acuity and central optical coherence tomography outcomes.
Keywords: Drugs; Neovascularization; Retina; Treatment medical.